Claudin 23 anticorps (AA 221-270)
-
- Antigène Voir toutes Claudin 23 (CLDN23) Anticorps
- Claudin 23 (CLDN23)
-
Épitope
- AA 221-270
-
Reactivité
- Humain, Souris, Rat, Singe
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Claudin 23 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marque
- IHC-plus™
- Specificité
- Human CLDN23 / Claudin 23
- Homologie
- Percent identity by BLAST analysis: Human (100%) Mouse (85%) Rat (84%).
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide located between aa221-270 of human CLDN23 (Q6ZW63, NP_919260). Percent identity by BLAST analysis: Human, Monkey (100%), Mouse (85%), Rat (84%).
Type of Immunogen: Synthetic peptide - Isotype
- IgG
- Top Product
- Discover our top product CLDN23 Anticorps primaire
-
-
- Indications d'application
- Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Antigène
- Claudin 23 (CLDN23)
- Autre désignation
- CLDN23 / Claudin 23 (CLDN23 Produits)
- Synonymes
- anticorps CLDN23, anticorps CLDNL, anticorps hCG1646163, anticorps 2310014B08Rik, anticorps claudin 23, anticorps si:ch211-95j8.2, anticorps CLDN23, anticorps si:ch211-95j8.2, anticorps Cldn23
- Sujet
-
Name/Gene ID: CLDN23
Family: Claudin
Synonyms: CLDN23, Claudin-23, CLDNL, HCG1646163, Claudin 23 - ID gène
- 137075
- NCBI Accession
- NP_919260
- UniProt
- Q96B33
- Pathways
- Cell-Cell Junction Organization, Hepatitis C
-